Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Embolic Stroke
- MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits
- MLC1501 Study Assessing Efficacy in STROke Recovery
- Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS)
- Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
- Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)
- Apixaban for Treatment of Embolic Stroke of Undetermined Source
- Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
- Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation
- Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
- Study of Antiplatelet Therapy for Intracranial Aneurysm Stent-assisted Coiling
- Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
- Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke